We used two-color flow cytometric analysis to investigate CD26+ (Tal +) cells in peripheral blood T lymphocytes from patients with human T-lymphotropic virus type-I (HTLV-I) associated myelopathy (HAM). The percentage of CD26 + cells among CD3 + cells was markedly increased in patients with HAM, compared with anti-HTLV-I seropositive carriers (p < 0.001) and seronegative controls (p < 0.01). Within the subpopulation of T cells, a significantly high percentage of CD26+ cells was detected in both CD4+ and CD8+ cell populations. Furthermore, analysis of HLA-DR+ T cells revealed similar results. In contrast CD4+CD45RA+ cells were significantly decreased in comparison with controls. These results suggest that immunologically activated or memory T cells found in peripheral blood may be etiologically relevant to HAM.
Introduction Subjects and Methods
At present, both "human T-lymphotropic virus type-I Subjects (HTLV-I) -associated myelopathy (HAM)" (1) and Peripheral blood lymphocytes (PBL) from 15 patients "HTLV-I-associated tropical spastic paraparesis" (2) are with HAM (4 men, ll women, age; 26-66) were studied, considered identical (3). However, regarding the patho-The diagnosis of HAM was based on the criteria described genesis of HAM/TSP, the mechanismbywhich HTLV-I by Osame et al (10) . For controls the PBL of anti infection causes chronic progressive myelopathy is still HTLV-I antibody seropositive carriers (2 men, 5 women, not known. Hafler et al have reported that Tal+ (CD26+) age; 41-77) and anti-HTLV-I antibody seronegative cells include T memory cells (4) and that the number of normal subjects (6 men, 9 women, age; 22-51) were CD26+ cells is related to the disease activity of multiple studied, From the First Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki and * the School of Allied Medical Sci Nagasaki University, Nagasaki Received for publication June 27, 1991; Accepted for publication June 29, 1992 Reprint requests should be addressed to Dr. Shigenobu Nagataki, the First Department of Internal Medicine, Nagasaki University School of Medicine, 7-1 Sakamoto-machi, Nagasaki 852, Japan 
CD26-Positive
T Cells in HAM subjects had an enhanced proliferative response to soluble recall Ag (for example, tetanus toxoid and mumps Ag) (4). In a study of Graves' disease, Eguchi et al reported that CD26+ cells may include antigen-triggered memory cells that react with thyroid-specific Ag (13). From the above findings, a possible explanation is that the increase in CD26+ cells in HAM patients may indicate an expan sion of the memory T cell population which recognize neuronal tissue-related Ag in the immunologically acti vated T cells. Another explanation is that the increase in this population may be related to a hyperimmune response to . Further investigation of the functional role of the activated or memory T cells in PBL from HAM patients will be necessary. This study was supported in part by a grant from the Neuroimmun ological Disease Research Committee of the Ministry of Health and Welfare, Japan
